RecruitingNot ApplicableNCT07642362

Digital Support for Multiple Myeloma Quality of Life

Digital Support for Enhancing the Quality of Life of Patients With Multiple Myeloma: An Observational, Randomized, Prospective Study (DigiMyQoL)


Sponsor

CareAcross

Enrollment

108 participants

Start Date

Feb 27, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this prospective study is to investigate the quality of life of patients with multiple myeloma and the effectiveness of support provided through a personalized web-based platform. Specifically, the study will compare Patient-Reported Outcomes (PROs) and the associated improvement in side effects and quality of life achieved through appropriate personalized educational and supportive content.


Eligibility

Inclusion Criteria2

  • Adult patients with newly diagnosed or relapsed/refractory multiple myeloma
  • Patients that are able to use the digital platform/application

Exclusion Criteria1

  • Patients that are not able to use the digital platform/application

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALDigital support

Personalized educational and supportive material, based on each patients' adverse events reported as PROs, delivered via the online platform.


Locations(1)

Alexandra General Hospital

Athens, Greece

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07642362


Related Trials